At Enteliqo, our intention is to augment humanity’s existence, via artificial intelligence and precision medicine for the greatest good of all. Our mission in life is to transform human health by increasing the accuracy, speed and convenience for diagnosis and treatment of life-threatening infections, chronic diseases and cancers, using advances in technology, machine learning and AI. Our vision is to positively impact 300 million patients across 18 countries by 2030.
To achieve that we actively:
1) Research, identify and invest in research and product development that leverages the most cutting-edge technology to deliver critical outcomes.
2) Drive positive disruptive change and create progress in human health.
3) Create an eco-system of world class experts to enable the successful end-to-end commercialisation of ground breaking products.
4) Partner with world-class research organisations and consultants in Strategy, Design-Thinking, Market Access, Regulatory Affairs, Clinical Trials, Health Economics, Pricing, Reimbursement, Digital Health, Digital Marketing, Accounting, Legal and Intellectual Property.
5) Influence thousands of key opinion leaders around the world, minimum 50 to 100 per country, reaching 3,000 hospitals across 18 countries.
6) Commercialise at least 3 products successfully every 5 years
7) And we give back, by ensuring products are affordable for patients in developing countries, democratisation of medicine matters to us.
Company’s Keywords:
precision medicine, machine learning, end to end commercialisation, healthcare ai, artificial intelligence
<0
<
<2020